Source-Backed Evidence Index / PubMed-linked reference
Cannabinoid Encyclopedia
Look up cannabinoid terms, compounds, targets, outcomes, safety topics, and source-backed research. Start simple, then open the evidence trail when you want the PubMed-level detail.
Type to search compounds, dictionary terms, outcomes, safety pages, targets, and research maps.
Why this exists
A PubMed-linked cannabinoid encyclopedia for normal readers.
Readers should be able to search a topic, understand the plain-English version, open the PubMed trail, and decide whether the evidence is mature, early, mechanistic, safety-relevant, or insufficient.
- SearchFind CBD, CBG, CBN, THC, sleep, inflammation, CB1, CB2, TRPV1, safety, or product-quality vocabulary.
- LearnUse guides and dictionary pages to translate normal questions into evidence routes.
- VerifyOpen source-backed pages, evidence rows, PubMed links, DOI links, and method notes.
- InspectRead quality standards for sourcing, testing, formulation, and transparency language.
- FollowJoin the digest for research updates, expert-review calls, and new education routes.
Reader Guides
Start with the questions people actually ask
Quality Literacy
Standards before confident claims
COA Literacy
Lab-report literacy gets its own public library.
No public batch COA examples are published yet. The structure is live now so readers can learn how lot IDs, lab reports, potency panels, contaminant screens, and caveats should fit together.
Choose a path
Core routes through the evidence graph
Start With Signal
Evidence-dense pages
Dictionary Hot Spots
Terms with the most exact evidence rows
Safety First
High-context safety pages
How To Read The Site
Plain English at the top, source trails underneath.
Every public page separates human, preclinical, mechanistic, safety, and insufficient evidence so a source can stay useful without becoming an overstatement.
- Find the topic.Search or browse by term, compound, target, outcome, safety area, or research map.
- Check the evidence posture.Look for human, preclinical, mechanistic, safety, conflicting, or insufficient labels.
- Open the source trail.Use PubMed and DOI links when a sentence needs verification.
Research Maps
Reviewed literature trails
Living Review Model
Built for correction, expansion, and expert review.
Pages are generated from reviewed workbench evidence rows. The public site is designed to accept new sources, show uncertainty, and keep source-backed statements traceable as the literature changes.
Browse By Volume
Largest source-backed pages
| Page | Type | Evidence Rows | Sources |
|---|---|---|---|
| CB1 biological target / canonical cannabinoid receptor | Target | 339 | 255 |
| CB2 biological target / canonical cannabinoid receptor | Target | 269 | 196 |
| THC compound / phytocannabinoid | Compound | 192 | 156 |
| CBD compound / phytocannabinoid | Compound | 166 | 139 |
| TRPV1 biological target / trp channel | Target | 144 | 96 |
| Cannabinoids other / compound class | Other | 143 | 127 |
| Immune modulation outcome | Outcome | 131 | 106 |
| Pregnancy and pediatrics safety topic | Safety | 129 | 106 |
| CBG compound / phytocannabinoid | Compound | 123 | 96 |
| CBC compound / phytocannabinoid | Compound | 112 | 83 |
| CBN-A compound / phytocannabinoid acid | Compound | 110 | 76 |
| Sleep outcome | Outcome | 110 | 69 |